Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD81 | P60033 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18723756 | 1.00 | CD81 (0.32) | CD81 | |
| SCHEMBL18723626 | 1.00 | CD81 (0.32) | CD81 | |
| SCHEMBL13397368 | 0.84 | CD81 (0.32) | CD81 | |
| SCHEMBL18723519 | 0.84 | CD81 (0.32) | CD81 | |
| SCHEMBL4332200 | 0.82 | CD81 (0.31) | CD81 | |
| SCHEMBL18723524 | 0.79 | ATM (0.41) | — | |
| SCHEMBL13784909 | 0.79 | EPHX2 (0.33) | — | |
| SCHEMBL4334479 | 0.79 | CD81 (0.33) | CD81 | |
| SCHEMBL13784912 | 0.77 | ALDH1A1 (0.36) | — | |
| SCHEMBL4905394 | 0.76 | GRM2 (0.38) | CD81 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2747886-B1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH & CIE (CH) | 2018-11-14 | — | — | EP | disclosed |
| EP-2970067-B1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH & CIE (CH) | 2017-08-16 | — | — | EP | disclosed |
| US-9714263-B2 | Selective hydrogenation of aldehydes with Ru/bidentate ligands complexes | FIRMENICH SA (CH) | 2017-07-25 | — | — | US | disclosed |
| US-20160039853-A1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2016-02-11 | — | — | US | disclosed |
| US-9090534-B2 | Selective hydrogenation of aldehyde with ru/bidentate ligands complexes | FIREMENICH SA (CH) | 2015-07-28 | — | — | US | disclosed |
| US-9090534-B2 | Selective hydrogenation of aldehyde with ru/bidentate ligands complexes | FIREMENICH SA (CH) | 2015-07-28 | — | — | US | disclosed |
| US-9090534-B2 | Selective hydrogenation of aldehyde with ru/bidentate ligands complexes | FIREMENICH SA (CH) | 2015-07-28 | — | — | US | disclosed |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2014-08-28 | — | — | US | disclosed |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2014-08-28 | — | — | US | disclosed |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2014-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160039853-A1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | ADH5, ADH1A, ADH1C | CD81 1439/4885 |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | ADH5, ADH1A, HAO2 | CD81 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.